Melanoma cell adhesion molecule

From WikiMD's Food, Medicine & Wellness Encyclopedia

Melanoma Cell Adhesion Molecule (MCAM), also known as CD146 or MUC18, is a cell adhesion molecule that plays a critical role in the cell adhesion processes that are essential for tumor progression and metastasis, particularly in melanoma, a type of skin cancer. MCAM is a member of the immunoglobulin superfamily and is involved in the mediation of heterophilic cell-cell interactions.

Function[edit | edit source]

MCAM functions as an adhesion molecule, facilitating the binding of melanoma cells to the endothelium, which is a critical step in the metastatic spread of melanoma cells. It is involved in various cellular processes, including cell migration, invasion, and angiogenesis, which are crucial for tumor growth and metastasis. The expression of MCAM has been found to correlate with the aggressiveness of melanoma, making it a potential target for cancer therapy.

Structure[edit | edit source]

The structure of MCAM includes an extracellular domain, a single transmembrane region, and a cytoplasmic tail. The extracellular domain is responsible for mediating cell-cell interactions, while the cytoplasmic tail is involved in signaling pathways that regulate cell migration and survival.

Clinical Significance[edit | edit source]

The expression of MCAM is not only a marker for melanoma progression but also has implications in other types of cancers, such as prostate cancer, breast cancer, and ovarian cancer. Its role in tumor angiogenesis makes it a potential target for anti-angiogenic therapies. Additionally, antibodies and inhibitors targeting MCAM are being explored as therapeutic strategies for melanoma and other cancers expressing this molecule.

Research and Therapeutic Approaches[edit | edit source]

Research on MCAM has led to the development of therapeutic approaches aimed at inhibiting its function. These include monoclonal antibodies that block MCAM-mediated cell adhesion and small molecule inhibitors that target signaling pathways activated by MCAM. Clinical trials are ongoing to evaluate the efficacy of these therapies in patients with melanoma and other cancers.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD